Stocks and Investing
Stocks and Investing
Mon, November 19, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, November 16, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Andrew Mok Initiated (AMED) at Hold and Held Target at $126 on, Nov 16th, 2018
Andrew Mok of UBS, Initiated "Amedisys, Inc." (AMED) at Hold and Held Target at $126 on, Nov 16th, 2018.
Andrew has made no other calls on AMED in the last 4 months.
There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kevin Ellich of "Craig-Hallum" Downgraded from Strong Buy to Hold and Decreased Target to $104 on, Friday, October 26th, 2018
- Whit Mayo of "Baird" Maintained at Hold with Increased Target to $120 on, Thursday, October 11th, 2018
- Joseph France of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $125 on, Thursday, October 11th, 2018
These are the ratings of the 2 analyists that currently disagree with Andrew
- Bill Sutherland of "Benchmark" Upgraded from Hold to Strong Buy on, Tuesday, October 30th, 2018
- Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $139 on, Tuesday, September 18th, 2018